Personal information

Websites & social links

LinkedIn
Reserach Gate
Academia

Keywords

mesenchymal stem cells, extracellular vesicles, microRNA, transcriptomics, biologics

Countries

Belgium

Activities

Collapse all

Employment (7)

EXO Biologics: Liege, BE

2022 to present | Scientific Expert Consultant (R&D)
Employment
Source: Self-asserted source
Gabrielis Kundrotas

EXO Biologics: Liege, BE

2019 to 2022 | Head of R&D, Senior Researcher
Employment
Source: Self-asserted source
Gabrielis Kundrotas

National Cancer Institute: Vilnius, LT

2018 to 2018 | Research Scientist (Laboratory of Immunology)
Employment
Source: Self-asserted source
Gabrielis Kundrotas

National Cancer Institute: Vilnius, LT

2016 to 2018 | Research Scientist (Biobank)
Employment
Source: Self-asserted source
Gabrielis Kundrotas

Baltic-American Medical & Surgical Clinic: Vilnius, LT

2015 to 2018 | Biologist Geneticist (Tissue Bank)
Employment
Source: Self-asserted source
Gabrielis Kundrotas

National Cancer Institute: Vilnius, LT

2011 to 2016 | Junior Research Associate (2012-2016 Biobank; 2011-2012 Carcinogenesis and Tumor Pathophysiology Laboratory)
Employment
Source: Self-asserted source
Gabrielis Kundrotas

Institute of Biotechnology: Vilnius, LT

2008 to 2010 | Part-time Research Student (Department of Eukaryote Gene Engineering)
Employment
Source: Self-asserted source
Gabrielis Kundrotas

Education and qualifications (3)

Vilnius University: Vilnius, LT

2011 to 2016 | Doctor of Philosophy (Ph.D.) (Faculty of Natural Sciences)
Education
Source: Self-asserted source
Gabrielis Kundrotas

Vilnius University: Vilnius, LT

2009 to 2011 | Master of Science (MSc) (Faculty of Natural Sciences)
Education
Source: Self-asserted source
Gabrielis Kundrotas

Vilnius University: Vilnius, LT

2005 to 2009 | Bachelor of Science (BSc) (Faculty of Natural Sciences)
Education
Source: Self-asserted source
Gabrielis Kundrotas

Funding (8)

Travel Grant to “The European Society of Human Genetics Conference 2015”, Glasgow, Scotland, UK

2015-06 to 2015-06 | Grant
The Sollus Foundation (Vilnius, LT)
Source: Self-asserted source
Gabrielis Kundrotas

Travel Grant to “COST Training School 2013”, Munich, Germany

2013-11 to 2013-11 | Grant
European Cooperation in Science and Technology (Brussels , BE)
Source: Self-asserted source
Gabrielis Kundrotas

Programming cells and management of tumor microenvironment for personal therapy in oncology – LASTER

2013 to 2015 | Grant
The European Union Structural Funds & the Ministry of Education and Science of the Republic of Lithuania (Vilnius, LT)
GRANT_NUMBER:

VP1-3.1-SMM-10-V-02-027
Source: Self-asserted source
Gabrielis Kundrotas

Travel Grant to “The 6th International Forum on Innovative Technologies for Medicine”, Bialystok, Poland

2012-11 to 2012-11 | Grant
Agency for Science, Innovation & Technology (Vilnius, LT)
Source: Self-asserted source
Gabrielis Kundrotas

Development of training of highly qualified professionals satisfying the requirements of the state and society in the field of biomedicine – BIOMEDOKT

2011 to 2016 | Grant
The European Union Structural Funds & the Ministry of Education and Science of the Republic of Lithuania (Vilnius, LT)
GRANT_NUMBER:

VP1-3.1-SMM-01- V-03-002
Source: Self-asserted source
Gabrielis Kundrotas

Synthesis of porcine Parvovirus protein in yeast and development of diagnostic system

2010-02 to 2010-05 | Grant
The Research Council of Lithuania (Vilnius, LT)
GRANT_NUMBER:

17/10/SMT10P-013
Source: Self-asserted source
Gabrielis Kundrotas

Investigation of monoclonal antibody specificity

2009-07 to 2009-08 | Grant
The Research Council of Lithuania (Vilnius, LT)
GRANT_NUMBER:

50/09/SP09-12
Source: Self-asserted source
Gabrielis Kundrotas

Synthesis of Rubella virus truncated nucleocapsid protein in yeast and investigation of its antigenic characteristics

2008-07 to 2008-09 | Grant
The Research Council of Lithuania (Vilnius, LT)
GRANT_NUMBER:

32/08/SP08-20
Source: Self-asserted source
Gabrielis Kundrotas

Works (19)

Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

Journal of Extracellular Vesicles
2024-02 | Journal article
DOI: 10.1002/jev2.12404
Contributors: Joshua A. Welsh; Deborah Goberdhan; Lorraine O'Driscoll; Edit Buzás; Cherie Blenkiron; Bussolati B; Joseph Whitley; Dolores Di Vizio; Tom A. P. Driedonks; Uta Erdbrügger et al.
Source: Self-asserted source
Gabrielis Kundrotas

Extracellular Vesicles From Mesenchymal Umbilical Cord Cells Exert Protection Against Oxidative Stress and Fibrosis in a Rat Model of Bronchopulmonary Dysplasia

Stem Cells Translational Medicine
2024-01-12 | Journal article | Author
DOI: 10.1093/stcltm/szad070
Contributors: Paola Bisaccia; Fabio Magarotto; Stefania D’Agostino; Arben Dedja; Silvia Barbon; Diego Guidolin; Cristina Liboni; Roberta Angioni; Giada De Lazzari; Federico Caicci et al.
Source: Self-asserted source
Gabrielis Kundrotas

Slow-Freezing Cryopreservation Ensures High Ovarian Tissue Quality Followed by In Vivo and In Vitro Methods and Is Safe for Fertility Preservation

Medicina
2020-10-19 | Journal article
DOI: 10.3390/medicina56100547
Contributors: Živilė Gudlevičienė; Kastytis Žilinskas; Gabrielis Kundrotas; Monika Grubliauskaitė; Daiva Baltriukienė; Virginija Bukelskienė
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Uptake and distribution of carboxylated quantum dots in human mesenchymal stem cells: cell growing density matters

Journal of Nanobiotechnology
2019-12 | Journal article
DOI: 10.1186/s12951-019-0470-6
Contributors: Gabrielis Kundrotas; Vitalijus Karabanovas; Marijus Pleckaitis; Marina Juraleviciute; Simona Steponkiene; Zivile Gudleviciene; Ricardas Rotomskis
Source: check_circle
Crossref

Microenvironment dependent gene expression signatures in reprogrammed human colon normal and cancer cell lines

BMC Cancer
2018-02-27 | Journal article
DOI: 10.1186/s12885-018-4145-8
Source: Self-asserted source
Gabrielis Kundrotas

Individual and combined effect of TP53, MDM2, MDM4, MTHFR, CCR5, and CASP8 gene polymorphisms in lung cancer

Oncotarget
2017-11-29 | Journal article
DOI: 10.18632/oncotarget.22756
Source: Self-asserted source
Gabrielis Kundrotas

New Reconstructive Technologies after Breast Cancer Surgery

Breast Cancer, Scientific and Clinical Aspects
2016 | Other
ISBN: 978-9986-784-99-9
Source: Self-asserted source
Gabrielis Kundrotas

Identity, proliferation capacity, genomic stability and novel senescence markers of mesenchymal stem cells isolated from low volume of human bone marrow

Oncotarget
2016-02-17 | Journal article
DOI: 10.18632/oncotarget.7456
Source: Self-asserted source
Gabrielis Kundrotas

Development of Quality Control protocol for clinical application of mesenchymal stem cells

Stem Cell Research in Lithuania: Past, Present and Future, Vilnius, Lithuania
2015-08-27 | Conference poster
Source: Self-asserted source
Gabrielis Kundrotas

Quick and effective method of bone marrow mesenchymal stem cell extraction

Open Medicine
2014-10-08 | Journal article
DOI: 10.1515/med-2015-0008
Source: Self-asserted source
Gabrielis Kundrotas

Stemness and genetic stability of human mesenchymal stem cells isolated from ultralow bone marrow volume

The 6th Baltic Congress of Oncology, Vilnius, Lithuania
2014-10-04 | Conference poster
Source: Self-asserted source
Gabrielis Kundrotas

Karyotype analysis of early passage mesenchymal stem cells isolated from frozen umbilical cord tissue

Science at Faculty of Natural Sciences, the 8th Scientific Conference, Vilnius, Lithuania
2014-10-03 | Conference poster
Source: Self-asserted source
Gabrielis Kundrotas

Quick and donor saving method for mesenchymal stem cell extraction for clinical use

The 12th Baltic Congress of Laboratory Medicine, Riga, Latvia
2014-09-19 | Conference abstract
Source: Self-asserted source
Gabrielis Kundrotas

Generation of recombinant porcine parvovirus virus-like particles in Saccharomyces cerevisiae and development of virus-specific monoclonal antibodies

Journal of Immunology Research
2014-06-19 | Journal article
DOI: 10.1155/2014/573531
Source: Self-asserted source
Gabrielis Kundrotas

Quick and donor-saving method for mesenchymal stem cell extraction for biobanking and clinical use

ESBB & BBMRI Conference, Verona, Italy
2013-10-08 | Conference poster
Source: Self-asserted source
Gabrielis Kundrotas

Surface markers distinguishing mesenchymal stem cells from fibroblasts

Acta medica Lituanica
2012 | Journal article
DOI: 10.6001/actamedica.v19i2.2313
Source: Self-asserted source
Gabrielis Kundrotas

Precise controlling of MSC characteristics during in vitro cultivation to ensure effective and safe stem cell application in clinical practice for advanced therapy in oncology

The 6th International Forum on Innovative Technologies for Medicine, Bialystok, Poland
2012-12-22 | Conference poster
Source: Self-asserted source
Gabrielis Kundrotas

Investigation of human mesenchymal stem cell genetic features to ensure their safety in clinical practice

Conference of Young Scientists 2012: Biofuture. Perspectives of Nature and Life Sciences, Vilnius, Lithuania
2012-12-05 | Conference abstract
Source: Self-asserted source
Gabrielis Kundrotas

Investigation of genetic features of mesenchymal stem cells to ensure safe treatment in oncology

The 11th Baltic Congress of Laboratory Medicine, Vilnius, Lithuania
2012-05-11 | Conference abstract
Source: Self-asserted source
Gabrielis Kundrotas
How many people are using ORCID?